doi:10.1074/jbc.REV120.014017
SURPASS demonstrated glycemic control superior to several active comparators
Vials commonly come in 2mL (20mg total tirzepatide) or 4mL (40mg total tirzepatide) sizes, depending on the prescription and dosing needs
TMAO and atherosclerosis Atherosclerosis, which is the major risk factor of CVDs, is characterized by foam cell formation, inflammatory cell recruitment, and endothelial dysfunction (61)
According to an observational study, patients who took Ozempic or another GLP-1 were 1.65 times more likely to develop deep vein thrombosis than patients in the control groups
Timper K, Grisouard J, Sauter NS et al (2013) Glucose-dependent insulinotropic polypeptide induces cytokine expression, lipolysis, and insulin resistance in human adipocytes